Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT1A receptors

Gen Comp Endocrinol. 2017 Dec 1:254:14-21. doi: 10.1016/j.ygcen.2017.09.006. Epub 2017 Sep 14.

Abstract

This study was designed to examine an anxiety-like behavior in the adult gonadectomized (GDX) male rats subjected to testosterone propionate (TP) treatment alone or in combination with 8-OH-DPAT, a 5-HT1A receptor agonist, or with NAN-190, 5-HT1A receptor antagonist. Two weeks after gonadectomy, GDX rats were subjected by treatments with the solvent, TP (0.5mg/kg, s.c.), 8-OH-DPAT (0.05mg/kg, s.c.), NAN-190 (0.1mg/kg, i.p.), TP in combination with 8-OH-DPAT or NAN-190 during 14days. Anxiety behavior was assessed in the elevated plus maze (EPM) and the open field test (OFT). 8-OH-DPAT treatment failed to modify the anxiety-like behavior of GDX rats in the EPM as compared to the GDX rats given with oil solvent. NAN-190 injected alone or in combination with TP to GDX rats resulted in a significant anxiolytic-like effect as compared to the GDX given with oil solvent or TP application. Our data indicate that the combination of NAN-190 and TP is more effective than TP alone in GDX rats inducing a more profound anxiolytic-like effect in the EPM. Thus, the results of this study suggest that effects of 5-HT1A receptor agonist/antagonist can modify anxiety level in opposite direction in male rats after gonadectomy.

Keywords: 5-HT(1A) receptors and anxiety; 8-OH-DPAT; Gonadectomy; NAN-190; Testosterone.

Publication types

  • Retracted Publication

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • 8-Hydroxy-2-(di-n-propylamino)tetralin / therapeutic use
  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Anti-Anxiety Agents / therapeutic use
  • Anxiety / drug therapy*
  • Anxiety / pathology
  • Behavior, Animal / drug effects*
  • Castration*
  • Male
  • Maze Learning / drug effects
  • Piperazines / pharmacology
  • Piperazines / therapeutic use
  • Rats, Wistar
  • Receptor, Serotonin, 5-HT1A / metabolism*
  • Serotonin 5-HT1 Receptor Antagonists / pharmacology
  • Serotonin 5-HT1 Receptor Antagonists / therapeutic use*
  • Serotonin Receptor Agonists / pharmacology
  • Testosterone / adverse effects*

Substances

  • Anti-Anxiety Agents
  • Piperazines
  • Serotonin 5-HT1 Receptor Antagonists
  • Serotonin Receptor Agonists
  • Receptor, Serotonin, 5-HT1A
  • 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine
  • Testosterone
  • 8-Hydroxy-2-(di-n-propylamino)tetralin